XDWY:XETRA:XETRA-Xtrackers MSCI World ESG Screened UCITS ETF 1D (EUR)

ETF | Others |

Last Closing

USD 24.46

Change

+0.13 (+0.51)%

Market Cap

USD 0.09B

Volume

1.08K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-10 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.16 (+0.29%)

USD 445.28B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 191.96B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.03 (-0.10%)

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.09 (+0.30%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.25 (+0.98%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.35 (+0.75%)

USD 102.61B
8R80:XETRA Amundi Index Solutions - Amund..

+0.74 (+0.53%)

USD 98.84B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.18 (+0.35%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.68 (+0.63%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.84 (+0.62%)

USD 80.38B

ETFs Containing XDWY:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.31% 57% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.31% 57% F 55% F
Trailing 12 Months  
Capital Gain 22.31% 78% C+ 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.31% 78% C+ 76% C+
Trailing 5 Years  
Capital Gain 31.36% 56% F 59% D-
Dividend Return 10.34% 64% D 50% F
Total Return 41.70% 61% D- 62% D
Average Annual (5 Year Horizon)  
Capital Gain 9.43% 61% D- 61% D-
Dividend Return 10.56% 64% D 63% D
Total Return 1.13% 74% C 53% F
Risk Return Profile  
Volatility (Standard Deviation) 11.67% 55% F 64% D
Risk Adjusted Return 90.46% 78% C+ 81% B-
Market Capitalization 0.09B 30% F 27% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.